Additionally, XSLJZD was found to downregulate TRPV1 and 5-HT expression levels in the duodenum of rats with FD, thereby alleviating gastric hypersensitivity, which may contribute to its therapeutic mechanisms for FD (Zhao et al., 2019). The gene discussed is TRPV1; the disease is Fabry disease.